Bimatoprost Generic Lumigan/Latisse 0.03% Eyelash Serum 3ml

What is generic bimatoprost eyelash serum?

Generic bimatoprost 0.03% is the unbranded equivalent of Lumigan and Latisse, containing the same active ingredient at the same concentration. Lumigan and Latisse are the two prescription brand names for bimatoprost; generic bimatoprost is clinically identical and typically more affordable.

Bimatoprost is a synthetic prostaglandin analogue. Originally licensed for glaucoma, it was found to produce a consistent and striking side effect: longer, thicker and darker eyelashes. It is now the most clinically proven ingredient for eyelash growth.

How bimatoprost grows lashes

Eyelashes cycle through three phases: growth (anagen), transition (catagen) and rest (telogen). Most lashes spend only a short time in anagen, which is why they stay short. Bimatoprost works by binding to prostaglandin receptors in the hair follicle, which:

• Extends the anagen (active growth) phase, so each lash grows for longer before it sheds
• Increases the proportion of follicles actively growing at any one time
• Stimulates melanin production in the follicle, darkening the lash shaft

The effect is cumulative. Lashes resting at the start of treatment enter the growth phase as the cycle turns, so results build progressively over 12-16 weeks.

Generic vs branded: Lumigan and Latisse

All three contain bimatoprost 0.03% and produce identical clinical results. The difference is brand and price only. Lumigan is the original ophthalmic brand (Allergan); Latisse is the same molecule repositioned for the US cosmetic market. Generic bimatoprost uses the same active ingredient, manufactured to the same pharmaceutical standards, at a lower cost. In the UK, most prescribers use either Lumigan or generic bimatoprost interchangeably for eyelash growth.

Results timeline

• 4-8 weeks: visible lengthening and thickening begins
• 12-16 weeks: full results, lashes at maximum length and density
• Ongoing use: results maintained with continued nightly application
• On stopping: lashes gradually return to pre-treatment state over several weeks

Clinical trials report up to 25% increase in lash length, 106% increase in thickness, and a significant increase in lash darkness.

How to apply

Apply once daily in the evening to clean, dry skin:

• Remove contact lenses; wait 15 minutes before reinserting after application
• Place a single drop onto a clean applicator or fine brush
• Draw along the base of the upper lash line only, as you would a thin line of eyeliner
• Blot any excess immediately below the lash line
• Do not apply to lower lashes directly (they receive treatment by contact transfer)
• Do not place drops directly in the eye

Side effects

Bimatoprost is well-tolerated when applied correctly to the upper lash line rather than into the eye.

Common (roughly 1 in 10)

• Skin darkening (hyperpigmentation) at the application site. Usually reverses when treatment stops
• Mild eye redness or irritation, particularly if solution reaches the eye directly

Uncommon (roughly 1 in 100)

• Itching or dryness of the eyelid margin
• Darkening of the eyelid skin

Rare (less than 1 in 1,000)

• Permanent iris pigmentation (darkening of the coloured part of the eye), mainly reported in glaucoma patients using bimatoprost as a direct eye drop over many years. The risk with correct upper lash-line application is very low

When to seek urgent medical advice

• Signs of allergic reaction: facial or lip swelling, difficulty breathing, rash
• Significant eye pain, blurred vision or new sensitivity to light

Not suitable during pregnancy or breastfeeding, or if you have active eye inflammation.

Prescription included

Complete the short online health questionnaire at checkout. A UK prescriber reviews it and most are approved the same day. Bimatoprost is then dispensed by a GPhC registered UK partner pharmacy and sent free by next-day delivery.